MAAT PHARMA | WebDisclosure

Basculer en Français

9480	Companies
185535	Keywords
117927	Articles
99378	Press releases

Home
Companies
MAAT PHARMA

BRIEF

published on 07/28/2025 at 07:35, 4 months 8 days ago

MaaT Pharma Secures €37.5 Million Loan to Boost Hemato-Oncology Programs

Clinical Development EIB Loan Hemato-oncology Microbiome Therapy Xervyteg® Approval
PRESS RELEASE

published on 07/28/2025 at 07:30, 4 months 8 days ago

Informations privilégiées / Autres communiqués
MaaT Pharma obtient 37,5 millions d'euros de la Banque Européenne d'Investissement pour soutenir ses programmes cliniques en hémato-oncologie. Financement structuré par tranches pour diversifier les sources de financement

Financement Banque Européenne D'investissement MaaT Pharma Biotechnologies Hémato-oncologie
PRESS RELEASE

published on 07/28/2025 at 07:30, 4 months 8 days ago

Inside Information / Other news releases
MaaT Pharma secures €37.5 million loan from the European Investment Bank to advance clinical programs in Hemato-Oncology. Funding supports late-stage assets Xervyteg® and MaaT033

European Investment Bank Clinical Programs Loan MaaT Pharma Hemato-oncology
BRIEF

published on 06/24/2025 at 20:05, 5 months 11 days ago

Assemblée Générale de MaaT Pharma : Résultats et Nominations

Kepler Cheuvreux Assemblée Générale Resolutions MaaT Pharma Nomination Président
BRIEF

published on 06/24/2025 at 20:05, 5 months 11 days ago

MaaT Pharma General Meeting: Results and Appointments

Kepler Cheuvreux Resolutions General Assembly MaaT Pharma Appointment Of President
PRESS RELEASE

published on 06/24/2025 at 20:00, 5 months 11 days ago

Inside Information / Other news releases
MaaT Pharma presents Annual General Meeting results, with shareholders approving most resolutions. Jean-Marie Lefevre appointed Chairman. Liquidity contract with Kepler Cheuvreux maintained

Annual General Meeting Shareholders Liquidity Contract MaaT Pharma Jean-Marie Lefevre
PRESS RELEASE

published on 06/24/2025 at 20:00, 5 months 11 days ago

Informations privilégiées / Autres communiqués
MaaT Pharma présente les résultats de son Assemblée Générale ordinaire annuelle et extraordinaire avec un quorum dépassant 73%. Résolutions approuvées concernant les comptes et la gouvernance

Gouvernance Assemblée Générale Résultats MaaT Pharma Comptes
BRIEF

published on 06/19/2025 at 19:05, 5 months 16 days ago

MaaT Pharma fait progresser ses efforts de commercialisation de Xervyteg®

Marché Européen Microbiome Essais Cliniques Oncologie Xervyteg®
BRIEF

published on 06/19/2025 at 19:05, 5 months 16 days ago

MaaT Pharma Advances Xervyteg® Commercialization Efforts

European Market Clinical Trials Oncology Microbiome Xervyteg®
PRESS RELEASE

published on 06/19/2025 at 19:00, 5 months 16 days ago

Informations privilégiées / Autres communiqués
MaaT Pharma fait le point sur ses activités et les principaux jalons attendus en 2025, notamment la demande d'AMM de Xervyteg® pour la maladie aiguë du greffon contre l'hôte auprès de l'EMA, ouvrant la voie à sa commercialisation en Europe

MaaT Pharma Maladie Aiguë Greffon Contre L'hôte Xervyteg Demande AMM

Accesswire

Published on 12/05/2025 at 19:50, 26 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 56 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 31 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 56 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 2 hours 16 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 18 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 50 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 1 minute ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 24 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 30 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 58 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 58 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 5 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 5 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 18 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE